BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 21555754)

  • 1. Use of acid-suppressive drugs and risk of fracture: a meta-analysis of observational studies.
    Eom CS; Park SM; Myung SK; Yun JM; Ahn JS
    Ann Fam Med; 2011; 9(3):257-67. PubMed ID: 21555754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis: risk of fractures with acid-suppressing medication.
    Kwok CS; Yeong JK; Loke YK
    Bone; 2011 Apr; 48(4):768-76. PubMed ID: 21185417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing proton pump inhibitors with histamin-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer disease.
    Park JH; Lee J; Yu SY; Jung JH; Han K; Kim DH; Rhee J
    BMC Geriatr; 2020 Oct; 20(1):407. PubMed ID: 33059626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of acid-suppressive drugs and risk of fracture in children and young adults: a meta-analysis of observational studies.
    Yang J; Zhou TJ; Yang J; Bao DN
    Eur J Clin Pharmacol; 2022 Mar; 78(3):365-373. PubMed ID: 34705066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies.
    Poly TN; Islam MM; Yang HC; Wu CC; Li YJ
    Osteoporos Int; 2019 Jan; 30(1):103-114. PubMed ID: 30539272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis.
    Eom CS; Jeon CY; Lim JW; Cho EG; Park SM; Lee KS
    CMAJ; 2011 Feb; 183(3):310-9. PubMed ID: 21173070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between use of acid-suppressive drugs and risk of gastric cancer. A nested case-control study.
    Tamim H; Duranceau A; Chen LQ; Lelorier J
    Drug Saf; 2008; 31(8):675-84. PubMed ID: 18636786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies.
    Yu EW; Bauer SR; Bain PA; Bauer DC
    Am J Med; 2011 Jun; 124(6):519-26. PubMed ID: 21605729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the association between hip fracture and acid-suppressive drug use in a UK primary care setting.
    Cea Soriano L; Ruigómez A; Johansson S; García Rodríguez LA
    Pharmacotherapy; 2014 Jun; 34(6):570-81. PubMed ID: 24634193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term proton pump inhibitor therapy and risk of hip fracture.
    Yang YX; Lewis JD; Epstein S; Metz DC
    JAMA; 2006 Dec; 296(24):2947-53. PubMed ID: 17190895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for falls with use of acid-suppressive drugs.
    Cea-Soriano L; Johansson S; García Rodríguez LA
    Epidemiology; 2013 Jul; 24(4):600-7. PubMed ID: 23676267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Acid Suppression Therapy Exposure and Fracture in Young Children.
    Malchodi L; Wagner K; Susi A; Gorman G; Hisle-Gorman E
    Pediatrics; 2019 Jul; 144(1):. PubMed ID: 31175146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients.
    Corley DA; Kubo A; Zhao W; Quesenberry C
    Gastroenterology; 2010 Jul; 139(1):93-101. PubMed ID: 20353792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies.
    Ngamruengphong S; Leontiadis GI; Radhi S; Dentino A; Nugent K
    Am J Gastroenterol; 2011 Jul; 106(7):1209-18; quiz 1219. PubMed ID: 21483462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014).
    Landi SN; Sandler RS; Pate V; Lund JL
    Gastroenterology; 2018 Mar; 154(4):861-873.e6. PubMed ID: 29122546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of proton pump inhibitors is associated with fractures in young adults: a population-based study.
    Freedberg DE; Haynes K; Denburg MR; Zemel BS; Leonard MB; Abrams JA; Yang YX
    Osteoporos Int; 2015 Oct; 26(10):2501-7. PubMed ID: 25986385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
    Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
    Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.
    Kwok CS; Arthur AK; Anibueze CI; Singh S; Cavallazzi R; Loke YK
    Am J Gastroenterol; 2012 Jul; 107(7):1011-9. PubMed ID: 22525304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acid suppressive drugs and gastric cancer: a meta-analysis of observational studies.
    Ahn JS; Eom CS; Jeon CY; Park SM
    World J Gastroenterol; 2013 Apr; 19(16):2560-8. PubMed ID: 23674860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.
    Dublin S; Walker RL; Jackson ML; Nelson JC; Weiss NS; Jackson LA
    Pharmacoepidemiol Drug Saf; 2010 Aug; 19(8):792-802. PubMed ID: 20623507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.